NEW YORK – Noninvasive prenatal diagnostics firm Ravgen has sued Natera for alleged infringement of two of its patents around cell-free DNA testing for genetic disorders.
In its complaint, filed on Monday in the US District Court for the Western District of Texas Waco Division, the Columbia, Maryland-based company claimed that Natera infringes its US Patents No. 7,727,720 and 7,332,277, both titled "Methods for detection of genetic disorders."